Are benzodiazepine recognition sites functional entities for the action of endogenous effector(s) or merely drug receptor(s)?
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D005442:Flumazenil; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011963:Receptors, GABA-A; D012640:Seizures / Q000139:chemically induced; D013570:Synaptic Membranes / Q000378:metabolism; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D001570:Benzodiazepinones; D018377:Neurotransmitter Agents; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D005442:Flumazenil; D005680:gamma-Aminobutyric Acid; D007538:Isoniazid